SCHEMBL6505992

SCHEMBL6505992

CCOP(=O)(CN1CCN(CCCOc2cc3ncnc(Nc4cccc(Br)c4)c3cc2N)CC1)OCC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 15/20 0.57
ERBB2 P04626 4/20 0.53
FBP1 P09467 4/20 0.53
ERBB4 Q15303 1/20 0.52
KDR P35968 3/20 0.48
SRC P12931 2/20 0.48
HDAC3 O15379 1/20 0.48
HDAC4 P56524 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC10 Q969S8 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
HDAC9 Q9UKV0 1/20 0.48
HDAC5 Q9UQL6 1/20 0.48
KDM4E B2RXH2 1/20 0.48
GAK O14976 1/20 0.48
MAPK13 O15264 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1419947 0.88 FBP1 (0.67) EGFRERBB2FBP1ERBB4
SCHEMBL1417820 0.87 EGFR (0.64) EGFRERBB2FBP1ERBB4KDR
SCHEMBL1418255 0.85 EGFR (0.81) EGFRERBB2ERBB4KDRSRC
SCHEMBL1418577 0.85 EGFR (0.61) EGFRERBB2FBP1ERBB4KDR
SCHEMBL1418523 0.85 EGFR (0.61) EGFRERBB2FBP1ERBB4KDR
SCHEMBL1418470 0.85 EGFR (0.61) EGFRERBB2FBP1ERBB4KDR
SCHEMBL7839812 0.85 EGFR (0.58) EGFRERBB2FBP1ERBB4KDR
SCHEMBL4226545 0.84 FBP1 (0.67) EGFRERBB2FBP1ERBB4KDR
SCHEMBL4222304 0.84 FBP1 (0.67) EGFRERBB2FBP1ERBB4KDR
SCHEMBL1417690 0.83 EGFR (0.63) EGFRERBB2KDRHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6972288-B1 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-12-06 US disclosed